AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Peltomaa, R Paimela, L Helve, T Leirisalo-Repo, M
Citation: R. Peltomaa et al., Effect of treatment on the outcome of very early rheumatoid arthritis, SC J RHEUM, 30(3), 2001, pp. 143-148

Authors: Peltomaa, R Paimela, L Harvey, S Helve, T Leirisalo-Repo, M
Citation: R. Peltomaa et al., Increased level of YKL-40 in sera from patients with early rheumatoid arthritis: a new marker for disease activity, RHEUM INTL, 20(5), 2001, pp. 192-196

Authors: Helenius, LMJ Hietanen, JH Helenius, I Kautiainen, H Piirainen, H Paimela, L Lappalainen, M Suuronen, R Lindqvist, C Leirisalo-Repo, M
Citation: Lmj. Helenius et al., Focal sialadenitis in patients with ankylosing spondylitis and spondyloarthropathy: a comparison with patients with rheumatoid arthritis or mixed connective tissue disease, ANN RHEUM D, 60(8), 2001, pp. 744-749

Authors: Albers, JMC Paimela, L Kurki, P Eberhardt, KB Emery, P van't Hof, MA Schreuder, FHJM Leirisalo-Repo, M van Riel, PLCM
Citation: Jmc. Albers et al., Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis, ANN RHEUM D, 60(5), 2001, pp. 453-458

Authors: Paimela, L Palosuo, T Aho, K Lukka, M Kurki, P Leirisalo-Repo, M von Essen, R
Citation: L. Paimela et al., Association of autoantibodies to filaggrin with an active disease in earlyrheumatoid arthritis, ANN RHEUM D, 60(1), 2001, pp. 32-35

Authors: Aman, S Paimela, L Leirisalo-Repo, M Risteli, J Kautiainen, H Helve, T Hakala, M
Citation: S. Aman et al., Prediction of disease progression in early rheumatoid arthritis by ICTP, RF land CRP. A comparative 3-year follow-up study, RHEUMATOLOG, 39(9), 2000, pp. 1009-1013

Authors: Peltomaa, R Leirisalo-Repo, M Helve, T Paimela, L
Citation: R. Peltomaa et al., Effect of age on 3 year outcome in early rheumatoid arthritis, J RHEUMATOL, 27(3), 2000, pp. 638-643

Authors: Mustila, A Paimela, L Leirisalo-Repo, M Huhtala, H Miettinen, A
Citation: A. Mustila et al., Antineutrophil cytoplasmic antibodies in patients with early rheumatoid arthritis - An early marker of progressive erosive disease, ARTH RHEUM, 43(6), 2000, pp. 1371-1377

Authors: Mottonen, T Hannonen, P Leirisalo-Repo, M Nissila, M Kautiainen, H Korpela, M Laasonen, L Julkunen, H Luukkainen, R Vuori, K Paimela, L Blafield, H Hakala, M Ilva, K Yli-Kerttula, U Puolakka, K Jarvinen, P Hakola, M Piirainen, H Ahonen, J Palvimaki, I Forsberg, S Koota, K Friman, C
Citation: T. Mottonen et al., Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial, LANCET, 353(9164), 1999, pp. 1568-1573

Authors: Mottonen, T Paimela, L Leirisalo-Repo, M Kautiainen, H Ilonen, J Hannonen, P
Citation: T. Mottonen et al., Outcome of patients with early rheumatoid arthritis over a two year period- Reply, ANN RHEUM D, 58(5), 1999, pp. 323-323

Authors: Dougados, M Combe, B Cantagrel, A Goupille, P Olive, P Schattenkirchner, M Meussr, S Paimela, L Rau, R Zeidler, H Leirisalo-Repo, M Peldan, K
Citation: M. Dougados et al., Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components, ANN RHEUM D, 58(4), 1999, pp. 220-225
Risultati: 1-11 |